In clinical practice, conversion from universal cytomegalovirus prophylaxis (CMV PPX) with valganciclovir (VGC) to targeted therapy (preemptive monitoring, PEM) is often pursued in the setting of leukopenia. It is unknown… Click to show full abstract
In clinical practice, conversion from universal cytomegalovirus prophylaxis (CMV PPX) with valganciclovir (VGC) to targeted therapy (preemptive monitoring, PEM) is often pursued in the setting of leukopenia. It is unknown if this is an effective strategy.
Keywords:
preemptive monitoring;
conversion;
cytomegalovirus;
prophylaxis;
valganciclovir
Journal Title: Transplant Infectious Disease
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transplant Infectious Disease
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!